S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
The Largest Ever Technology Wave Is Coming! (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
The Largest Ever Technology Wave Is Coming! (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
How to Invest in AI's Fast-Growing Market (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
The Largest Ever Technology Wave Is Coming! (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
The Largest Ever Technology Wave Is Coming! (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
How to Invest in AI's Fast-Growing Market (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
The Largest Ever Technology Wave Is Coming! (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
The Largest Ever Technology Wave Is Coming! (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
How to Invest in AI's Fast-Growing Market (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
The Largest Ever Technology Wave Is Coming! (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
The Largest Ever Technology Wave Is Coming! (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
How to Invest in AI's Fast-Growing Market (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
NYSE:AVNS

Avanos Medical (AVNS) Stock Forecast, Price & News

$23.39
+0.41 (+1.78%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$22.95
$23.55
50-Day Range
$22.53
$30.98
52-Week Range
$19.32
$31.99
Volume
250,100 shs
Average Volume
251,066 shs
Market Capitalization
$1.09 billion
P/E Ratio
25.42
Dividend Yield
N/A
Price Target
$30.25

Avanos Medical MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
29.3% Upside
$30.25 Price Target
Short Interest
Healthy
1.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.78mentions of Avanos Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.95%
From $1.64 to $2.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Medical Sector

64th out of 1,009 stocks

Surgical Appliances & Supplies Industry

6th out of 20 stocks


AVNS stock logo

About Avanos Medical (NYSE:AVNS) Stock

Avanos Medical, Inc. is a medical technology company. It engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Stock News Headlines

Avanos Medical (NYSE:AVNS) Shares Gap Up to $22.53
The Largest Ever Technology Wave Is Coming!
This summer, a small tech company will launch a key technology to advance artificial intelligence, or AI, that can think, reason and make decisions like humans. It will change the world, just like electricity did.
How to Invest in AI's Fast-Growing Market
The AI market stands at $160 billion in 2023. Estimates are the AI market will grow 20-fold to $1.8 TRILLION by 2030. One little-known company is looking to win big with a new network technology no one else has. AI could explode... and soon.
StockNews.com Lowers Avanos Medical (NYSE:AVNS) to Buy
Q1 2023 Avanos Medical Inc Earnings Call
Recap: Avanos Medical Q1 Earnings
See More Headlines
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Company Calendar

Last Earnings
5/03/2023
Today
5/29/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
4,044
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.25
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+29.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$50.50 million
Pretax Margin
7.06%

Debt

Sales & Book Value

Annual Sales
$820 million
Cash Flow
$2.71 per share
Book Value
$27.77 per share

Miscellaneous

Free Float
45,314,000
Market Cap
$1.09 billion
Optionable
Optionable
Beta
0.93

Key Executives

  • Joseph F. Woody
    Chief Executive Officer & Executive Director
  • Michael C. Greiner
    Chief Financial & Transformation Officer, SVP
  • Lee Burnes
    Senior VP-Global Research & Development
  • Michelle Scharfenberg
    Chief Ethics & Compliance Officer, Senior VP
  • Mojirade Amanda James
    Secretary, Senior Vice President & General Counsel













AVNS Stock - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View AVNS analyst ratings
or view top-rated stocks.

What is Avanos Medical's stock price forecast for 2023?

3 brokerages have issued 1 year price objectives for Avanos Medical's shares. Their AVNS share price forecasts range from $28.00 to $34.00. On average, they predict the company's share price to reach $30.25 in the next twelve months. This suggests a possible upside of 29.3% from the stock's current price.
View analysts price targets for AVNS
or view top-rated stocks among Wall Street analysts.

How have AVNS shares performed in 2023?

Avanos Medical's stock was trading at $27.06 at the beginning of 2023. Since then, AVNS stock has decreased by 13.6% and is now trading at $23.39.
View the best growth stocks for 2023 here
.

Are investors shorting Avanos Medical?

Avanos Medical saw a decrease in short interest in April. As of April 15th, there was short interest totaling 865,700 shares, a decrease of 7.4% from the March 31st total of 935,300 shares. Based on an average daily volume of 240,400 shares, the short-interest ratio is presently 3.6 days. Currently, 1.9% of the shares of the company are short sold.
View Avanos Medical's Short Interest
.

When is Avanos Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AVNS earnings forecast
.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) released its earnings results on Wednesday, May, 3rd. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by $0.01. The company earned $191.70 million during the quarter, compared to analyst estimates of $195.20 million. Avanos Medical had a net margin of 5.34% and a trailing twelve-month return on equity of 6.11%. Avanos Medical's revenue for the quarter was down 2.9% on a year-over-year basis. During the same period last year, the company posted $0.26 earnings per share.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $1.60-$1.80 for the period, compared to the consensus estimate of $1.70. The company issued revenue guidance of -.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.98%), Dimensional Fund Advisors LP (6.80%), State Street Corp (4.34%), Macquarie Group Ltd. (4.26%), Geode Capital Management LLC (1.88%) and Charles Schwab Investment Management Inc. (1.42%).
View institutional ownership trends
.

How do I buy shares of Avanos Medical?

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $23.39.

How much money does Avanos Medical make?

Avanos Medical (NYSE:AVNS) has a market capitalization of $1.09 billion and generates $820 million in revenue each year. The company earns $50.50 million in net income (profit) each year or $0.92 on an earnings per share basis.

How many employees does Avanos Medical have?

The company employs 4,044 workers across the globe.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com.

This page (NYSE:AVNS) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -